In addition, for the purpose of the specific requirements for equine animals as regards African horse sickness and Venezuelan equine encephalomyelitis set out in Annex XI, points 2.1 and 2.2, to Delegated Regulation (EU) 2020/692, it is necessary to lay down a definition of a ‘vector-protected establishment’ in Article 2 of that Delegated Regulation. There is already a definition of ‘vector-protected establishment’ in Article 2 of Commission Delegated Regulation (EU) 2020/689 [Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (OJ L 174, 3.6.2020, p. 211).] in the context of infection with bluetongue virus (serotypes 1-24). Therefore, the definition of a ‘vector-protected establishment’ in Article 2 of Delegated Regulation (EU) 2020/692, for the purpose of African horse sickness and Venezuelan equine encephalomyelitis, should be consistent with the definition of the ‘vector-protected establishment’ in Article 2 of Delegated Regulation (EU) 2020/689. Article 2 of Delegated Regulation (EU) 2020/692 should therefore be amended accordingly.
Recital 4, Regulation (EU) 2023/119
In forcesince 9 Nov 2022